|
levitra versus cialis Ted extensive clinical testing levitra versus cialis, and both drugs have gained FDA's approval. Both are inhibitors of type 5 phosphodiesterase (PDE-5) levitra versus cialis, thus sharing the same basic mechanism of sildenafil (Viagra levitra versus cialis, Pfizer) levitra versus cialis, which was approved in March levitra versus cialis, 1998. All three are taken orally prior to planned sexual activity levitra versus cialis, acting to increase blood flow in the penis in response to sexual stimulation. However levitra versus cialis, there are important differences between the three levitra versus cialis, differences that could influence safety levitra versus cialis, specificity levitra versus cialis, duration of action levitra versus cialis, and ultimately levitra versus cialis, public acceptance within this class of drug. Giles Brindley and Drug Therapy for ED Modern drug therapy for ED was advanced enormously in 19 levitra versus cialis.
levitra versus cialis 83 when British physiologist Giles Brindley levitra versus cialis, Ph.D. dropped his trousers and demonstrated to a shocked AUA audience his phentolamine-induced erection. The drug Brindley injected into his penis was a non-specific vasodilator levitra versus cialis, an alpha-blocking agent levitra versus cialis, and the mechanism of action was clearly corporal smooth muscle relaxation. The effect that Brindley discovered levitra versus cialis, established the fundamentals for the later development of specific levitra versus cialis, safe levitra versus cialis, orally-effective drug therapies levitra versus cialis, ie levitra versus cialis, PDE-5 inhibitors. PDE Inhibition and Smooth Muscle Relaxation Phosphodiesterase (PDE) is an enzyme that causes breakdown of cyclic GMP levitra versus cialis, which is the direct intracellular mediator in the nitric oxide (nonadrenergic levitra versus cialis, noncholinergic) pathway. Discovery of this pathway led to a Nobel Prize in 1998 for the scientists responsible. The nitric oxide system causes relaxation of smooth muscle in blood vessel walls levitra versus cialis, ie levitra versus cialis, vasodilation levitra versus cialis, in various organ systems. The direct intracellular mediator of the nitric oxide pathway is cGMP. PDE catalyzes the degradation of cGMP. This pathway is active in numerous organ systems levitra versus cialis, and as of this writing levitra versus cialis, a number of different PDEs are known. The various PDEs differ in their physiologic roles and tissue distribution. Type 5 PDE is concentrated in the penile smooth muscle of the corpus cavernosum levitra versus cialis, where its normal function is .
levitra versus cialis Ide (nonadrenergic levitra versus cialis, noncholinergic) pathway. Discovery of this pathway led to a Nobel Prize in 1998 for the scientists responsible. The nitric oxide system causes relaxation of smooth muscle in blood vessel walls levitra versus cialis, ie levitra versus cialis, vasodilation levitra versus cialis, in various organ systems. The direct intracellular mediator of the nitric oxide pathway is cGMP. PDE catalyzes the degradation of cGMP. This pathway is active in numerous organ systems levitra versus cialis, and as of this writing levitra versus cialis, a number of different PDEs are known. The various PDEs differ in their physiologic roles and tissue distribution. Type 5 PDE is concentrated in the penile smooth muscle of the corpus cavernosum levitra versus cialis, where its normal function is t.
levitra versus cialis 
levitra versus cialis | | | | | |
levitra versus cialis
|
